BCL2/adenovirus E1B 19kDa Interacting Protein 1 (BNIP1) (Middle Region) Peptid
BNIP1
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5510996
Kurzübersicht für BCL2/adenovirus E1B 19kDa Interacting Protein 1 (BNIP1) (Middle Region) Peptid (ABIN5510996)
Target
BNIP1
(BCL2/adenovirus E1B 19kDa Interacting Protein 1 (BNIP1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- DNLEKAELLQ GGDLLRQRKT TKESLAQTSS TITESLMGIS RMMAQQVQQS
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- BNIP1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
BCL2/adenovirus E1B 19kDa Interacting Protein 1 (BNIP1) peptide
BNIP1 Reaktivität: Human, Maus, Ratte Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BNIP1 (BCL2/adenovirus E1B 19kDa Interacting Protein 1 (BNIP1))
-
Hintergrund
-
This gene is a member of the BCL2/adenovirus E1B 19 kd-interacting protein (BNIP) family. It interacts with the E1B 19 kDa protein, which protects cells from virally-induced cell death. The encoded protein also interacts with E1B 19 kDa-like sequences of BCL2, another apoptotic protector. In addition, this protein is involved in vesicle transport into the endoplasmic reticulum. Alternative splicing of this gene results in four protein products with identical N- and C-termini.
Alias Symbols: NIP1, SEC20, TRG-8
Protein Size: 271 -
Gen-ID
- 662
-
NCBI Accession
- NM_001205, NP_001196
Target
-
Sie sind hier:
